MedPath

Multi-center randomized controlled trial to evaluate oral vitamin B12 treatment for vitamin B12 deficiency after total gastrectomy in gastric cancer patients

Not Applicable
Recruiting
Conditions
gastric cancer
Registration Number
JPRN-UMIN000030727
Lead Sponsor
yokohama city university
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
160
Inclusion Criteria

Not provided

Exclusion Criteria

1:Synchronous or metachronous cancer (synchronous multiple cancers in the stomach included). 2:Allergic reaction to vitamin B12 3:Systemic treatment with vitamin B12 4:Peripheral neuropathy with other causes 5:Received adjuvant chemotherapy for gastric cancer 6:Any other medical conditions that made a patient unsuitable for inclusion in the study according to the opinion of the investigator were also considered to be exclusion criteria for this study

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The incidence of vitamin B12 levels below 200 pg/ml after 12 weeks treatment
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath